We analyse the latest round of financing raised by the company Outvise, valued at €1.2m, from the perspective of corporate finance.
M&A advisors with expertise in the technology sector
Blog
Latest Sectoral Reports |
There is not content matching the selected criteria
Last Entries
SUMITOMO'S ASSESSMENT AFTER ITS LATEST ACQUISITION
Sumitomo Mitsui Financial Group will formalise the acquisition of TT International for an amount close to €170 million. We analyse this transaction from a corporate finance perspective.
CASAFARI RAISES €5M AND CONTINUES ITS EXPANSION
We analyse the €5m raised by Casafari, a company dedicated to the development of real estate market classification through A.I., from a corporate governance perspective.
ABILITY PHARMACEUTICALS RAISES €3.5M TO LICENSE ONCOLOGY DRUG
We take a corporate finance look at the latest round of financing raised by Ability Pharmaceuticals to license its oncology drug.
ACCENTURE BUYS PRAGSIS BIDOOP AND STRENGTHENS ITS A.I. AND BID DATA BUSINESSES
We analyse from a corporate finance perspective Accenture's latest acquisition: Pragsis Bidoop, a Spanish company specialising in Artificial Intelligence and Big Data.
CELLNEX TELECOM BUYS IRELAND'S CIGNAL FOR 210M€.
We analyse Cellnex Telecom's acquisition of Cignal from the Corporate Finance perspective.
VALUATION OF ACCENTURE FOLLOWING ITS LATEST ACQUISITIONS
Accenture continues its inorganic growth plan with its latest purchase, the acquisition of Fairway Technologies. We analyse this acquisition from a corporate finance perspective.
URBVAN CAPTURES 9M$ TO PROMOTE URBAN MOBILITY
Corporate finance is also coming to urban mobility apps for large cities, as reflected in the latest round closed by Urbvan.
NAZCA'S LATEST PURCHASES.
We analyse Nazca's latest acquisitions from a corporate finance perspective: the companies Cinelux, Diater and Terratest.
KENMEI TECHNOLOGIES RAISES €1M, ACCELERATES PRODUCT DEVELOPMENT
Kenmei Technologies, specialising in mobile network intelligence and automation, raises €1m to develop its product. We analyse it from Corporate Finance.
VIVEBIOTECH INCREASES ITS CAPITAL BY €3.5M AND REINFORCES ITS GROWTH
We analyse the €3.5m raised by ViveBiotech, a Spanish company that produces antiviral vectors, from a corporate finance perspective.
BANCO SABADELL'S INNOCELLS PARTICIPATES IN 5.5M$ ROUND FOR KOVRR
Corporate Finance takes a look at the latest 5.5M$ funding round received by Kovrr, an Israeli cyber risk company.